Jump to content

News Forum - New drug marks major milestone in slowing Alzhemier’s


Recommended Posts

A new drug is marking a major milestone in slowing the impacts of Alzheimer’s disease. The drug, Lecanemab, reduces memory decline in Alzheimer’s patients, as shown in its recent trial. Lecanemab is given to patients every two weeks. The drug clears a protein called amyloid, that builds up in the brains of people with Alzheimer’s. Amyloid is believed to be a key cause of the disease. Alzheimer’s patients are currently given other drugs to help manage their symptoms. However, none of these drugs change the trajectory of the disease.  In a trial for the new Lecanemab drug, a total of […]

The story New drug marks major milestone in slowing Alzhemier’s as seen on Thaiger News.

Read the full story

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Unfortunately, your content contains terms that we do not allow. Please edit your content to remove the highlighted words below.
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Create New...

Important Information

By posting on Thaiger Talk you agree to the Terms of Use